Post-earnings recap
Reported
Mon, Jan 30, 2012
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Haemonetics Corp's earnings report indicates a struggle to meet expectations, particularly in EPS, which fell short by 10.89%. The stock reacted negatively, dropping 1.86%, likely reflecting investor concerns about the company's current performance and lack of guidance. This could lead to increased scrutiny from investors as they assess the company's future direction and strategies.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.72 | N/A | -10.89% |
Overall, management expressed caution regarding current market conditions. They highlighted the need for ongoing adjustments to their business strategies.
Management acknowledged challenges in meeting earnings expectations.
They emphasized a focus on long-term strategies despite short-term setbacks.